Ana Ramirez De Molina

PhD in Biochemistry and Molecular Biology (UAM, Madrid, extraordinary award, 2002), Ana Ramirez de Molina has developed her scientific career in the relationship between metabolism, nutrition and cancer. She has worked at the Translational Oncology Unit CSIC-UAM-Hospital la Paz in Madrid, with long stages at Royal Marsden Hospital in London and Sloan Kettering Cancer Center in New York. Author of more than 80 articles of impact in the area and several patents transferred to the industry, she has worked as Director of R&D at TCD Pharma, spin-off from CSIC where she conducted a “first in class” drug to Phase I of clinical trials for cancer patients. Afterwards she joined IMDEA Food as a researcher within the Ramón y Cajal program, where she currently leads the Precision Nutrition Program in Cancer and the GENYAL platform for clinical trials in nutrition and health, and participates in the management of the center as Deputy Director since 2014. She has promoted the creation of two IMDEA and UAM spin-off companies, directed 8 Doctoral Theses, and participated in numerous courses, and evaluation panels both nationally and internationally. She has received the MSD Young Researchers Award, the Nestle-nutrition international John Kinney Award, and the 8 March distinction from the Community of Madrid as an outstanding woman in Science and Technology.